Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1NET 1Myeloid 1Endocrine 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 77Leukemia, Myeloid, Acute 72Leukemia, Myelogenous, Chronic, BCR-ABL Positive 34Myeloproliferative Disorders 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Non-Hodgkin 21Primary Myelofibrosis 18Leukemia, Myelomonocytic, Chronic 17Hodgkin Disease 15Leukemia 14Myelodysplastic-Myeloproliferative Diseases 12Polycythemia Vera 10Leukemia, Biphenotypic, Acute 10Histiocytosis, Langerhans-Cell 10Anemia, Refractory, with Excess of Blasts 10Sarcoma 9Neuroblastoma 9Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Glioma 9Wilms Tumor 8Rhabdoid Tumor 8Neuroectodermal Tumors, Primitive, Peripheral 8Medulloblastoma 8Hepatoblastoma 8Ependymoma 8Blast Crisis 8Thrombocythemia, Essential 7Rhabdomyosarcoma 7Osteosarcoma 7

Interventions

trametinib 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroma × Myeloid × 30 days × Clear all
NCT03975829 2026-06-02

Pediatric Long-Term Follow-up and Rollover Study

Novartis

Phase 4 Recruiting
165 enrolled
CNSMyeloid

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡